RE: James Anderson Money Week Interview13 May 2022 14:57
This year, as holders will know, has not been quite so good. Overall, it is now down nearly 50% in the last six months – and it has fallen 12% in the last five days alone. Shares in biotech group and Covid vaccine maker Moderna, the trust’s top holding, are down 43% year to date and those in electric car maker Tesla, possibly the firm Anderson is most famous for backing, are down 33%. SMIT also trades on a 7% discount to its net asset value (NAV – the value of its underlying portfolio), something that would have been genuinely unimaginable a year ago (even with this discount, the average premium over the last year has been 0.14%, a number that reflects previous premiums).
The trust is in the MoneyWeek model investment trust portfolio and I hold it myself (as for that matter does Anderson, who tells me that the “vast majority” of his own wealth is held in SMIT shares). Every time we write about it I remind you that success rarely goes in a straight line (in performance terms at least) in the fund management industry and that you must rebalance your portfolio regularly (in this case selling down SMIT and shifting the money made into the more value-orientated/capital-preservation names). I have done that myself (though this week has sunk most ships so nothing I have shifted into is causing much celebration) and I hope you have, too. But an hour with Anderson and you will want to keep holding what you have left.
Most stocks are disappointing
We start with what went right (until this year at least). It all began, says Anderson, post the great financial crisis (GFC). At the time Baillie Gifford talked a good game about being long-term investors but it wasn’t really so: “much of Baillie Gifford’s process and philosophy was also broken” (think “endless discussions of quarterly performance”). So they stopped, rethought everything and decided to become a “truly global, truly long-term” investment firm. That involved recognising that most investment theory isn’t really valid in the real world – the key truth being that stockmarket performance is not a “perfect bell curve”. Instead, the majority of long-term returns come from a tiny percentage of listed companies (the academics Baillie Gifford works with have it at around 4%). The challenge, then, is to find the brilliant few.
Until recently this went almost too well – the “hit rate” was so high that too much money was attracted to the strategy (there was a “rush to imitate” Baillie Gifford). But the short-term falls in share prices are, he reckons, just that. “I reject the notion that this is all over,” says Anderson. You might say to that: well, he would, wouldn’t he? But he does makes a good case.